STUDY SEARCH RESULTS

1 study found for your search request:  1654-004

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)
Condition: Respiratory syncytial virus infection
Minimum Age: N/A, Maximum Age: 1 years
Gender: All
Study ID: NCT04767373
Status: Completed
Has Results




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site